BNP Paribas Financial Markets’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-315
| Closed | -$2.9K | – | 3713 |
|
|
2017
Q1 | $2.9K | Sell |
315
-184
| -37% | -$1.7K | ﹤0.01% | 2878 |
|
|
2016
Q4 | $3.85K | Sell |
499
-1,028
| -67% | -$7.93K | ﹤0.01% | 3182 |
|
|
2016
Q3 | $17.5K | Buy |
1,527
+881
| +136% | +$10.1K | ﹤0.01% | 2969 |
|
|
2016
Q2 | $7.95K | Buy |
+646
| New | +$7.95K | ﹤0.01% | 3033 |
|
|
2016
Q1 | – | Sell |
-3,338
| Closed | -$75.2K | – | 3579 |
|
|
2015
Q4 | $75.2K | Sell |
3,338
-171
| -5% | -$3.85K | ﹤0.01% | 2520 |
|
|
2015
Q3 | $58.2K | Buy |
3,509
+2,102
| +149% | +$34.9K | ﹤0.01% | 2752 |
|
|
2015
Q2 | $31.7K | Buy |
1,407
+1,106
| +367% | +$24.9K | ﹤0.01% | 2757 |
|
|
2015
Q1 | $7.76K | Buy |
+301
| New | +$7.76K | ﹤0.01% | 2893 |
|
|
2014
Q4 | – | Sell |
-1,261
| Closed | -$23.9K | – | 3631 |
|
|
2014
Q3 | $23.9K | Buy |
+1,261
| New | +$23.9K | ﹤0.01% | 2592 |
|